Experimental Dermatology and Cutaneous Biology
2024 Activity indicators
- 4 public competitive projects: MICINN-MINECO, ISCIII, CAM
- 9 private projects led
- 41 clinical trials
- 61 publications
- IF: 216.00
- Q1 publications: 33 (54%)
- D1 publications: 10 (16%)
- 3 thesis
- 5 awards
- Translation: 2nd TricoHRC Trichology Practical Handbook
- National public agency evaluators: 4 researchers
- Members of editorial committees: 3 researchers
- 10 days stay in foreign institutions:
- Showa Pharmaceutical University (Machida, Tokyo)
- 5 visitors hosted and 40 months of stay:
- Cleveland Clinic University Hospitals (EEUU)
- Blauvelt consulting LLC (EEUU)
- Warsaw University (Poland)
- Bologna University (Italy)
Milestones
- Doctors Pedro Jaén and Sergio Vañó have been selected by FORBES magazine as the best dermatologists in Spain 2024.
- In 2024, the research group on psoriasis and cardiovascular risk, led by Dr. Álvaro González-Cantero, published two original articles in one of the most important research journals in the specialty (Journal of Investigative Dermatology), in addition to multiple other articles in high-impact journals.
- The group has received funding for a clinical trial designed by the team itself, entitled "Study on the effects of the Mediterranean diet in patients with psoriasis (MEDIPSO)". This is a highly relevant study, as it contributes to the generation of independent scientific knowledge and promotes healthy habits in society.
- The group's scientific collaborations with prestigious national and international research centers reflect its global reach, reflected in joint publications and international visits.
- During 2024, 3 doctoral theses have been read by collaborators of the research group, showing their commitment tohigh level research in Dermatology.
Bibliometrics
Articles | Accum. IF | Mean IF | Articles Q1 or Q2 | % in Q1 or Q2 | Articles D1 | % in D1 | |
---|---|---|---|---|---|---|---|
2020 | 59 | 296.17 | 6.04 | 42 | 71 | 24 | 41 |
2021 | 44 | 284.95 | 8.38 | 29 | 66 | 16 | 36 |
2022 | 37 | 182.59 | 6.30 | 20 | 54 | 7 | 19 |
2023 | 48 | 213.56 | 5.48 | 37 | 77 | 8 | 17 |
2024 | 61 | 216.00 | 5.14 | 39 | 64 | 10 | 16 |
249 | 1193.30 | 6.27 | 167 | 66 | 65 | 26 |
* Only original articles, editorials, guidelines and reviews.